Open AccessSelinexor + Dexamethasone in Triple-Class Refractory Multiple Myeloma
Author(s) -
Richard Simoneaux
Publication year - 2019
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000615268.28085.c1
Subject(s) - medicine , multiple myeloma , dexamethasone , clinical trial , refractory (planetary science) , population , oncology , clinical endpoint , carfilzomib , proteasome inhibitor , astrobiology , physics , environmental health